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Abstract
Background: To asses the effect of menopause on the corneal curvature changes using corneal
computerized videokeratography (CVK) in premenopausal and postmenopausal healthy women.
Methods: Thirty-six postmenopausal women with mean ages of 49.2 (range 39 to 57) were
enrolled in this randomized, prospective study, comparing with 26 healthy controls with mean ages
of 38.5 +/- 4.9 (range 32 to 49). Subjects were determined to be postmenopausal, by the
Gynecology and Obstetrics Department, based on blood Follicular Stimulating Hormone (FSH),
Luteinizing Hormone (LH), Estradiol, Progesterone levels and clinical complaints. Complete
ophthalmic examination and CVK using Haag-Streit System was performed in both premenopausal
and postmenopausal women.
Results:  Mean horizontal curvature and vertical curvature of central corneal power in
premenopausal women were 43.5 +/- 1.25 Diopter (D), and 44.1 +/- 1.53 D. Mean horizontal
curvature and vertical curvature of central corneal power in postmenopausal women were 43.9 +/
- 1.4 D, and 44.6 +/- 1.3 D. The mean keratometric astigmatisms of premenopausal and
postmenopausal women were 0.81 +/- 0.57 D (4–179 degrees), 0.74 degrees +/- 0.5 D (1–180
degrees) respectively. No significant corneal curvature changes were detected between
premenopausal and postmenopausal groups (P > 0.05). On the other hand, we only found negative
but significant correlation between horizontal corneal curvature and estrogen level of
postmenopausal women (r = -0.346, p = 0.038).
Conclusion: Menopause is physiologic process and may also affect corneal topographic changes.
In postmenopausal women, corneal steeping was observed minimally compared to premenopausal
women. The results suggest that changes in estrogen level of women with menopause are
associated with slightly alteration of horizontal curvature of cornea.
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Background
Corneal functions can be regulated by sex hormones that
have been reported by epidemiologic studies; however,
the mechanism of this phenomenon is not apparent. The
estrogen receptor (ER), progesterone receptor (PR) and
androgen receptor (AR) were found in the nuclei of
human corneal epithelial, stromal and endothelial cells
[1-3].
The corneal variables, which change during the menstrual
cycle, include corneal thickness, curvature, and sensitivity.
A change in thickness during the menstrual cycle of
women has been reported; the percentage of increase in
thickness was 5.6 % on days of 15 and 16 [4]. There are
also reports that show an increase in the corneal thickness
during pregnancy. An increase of 3 percent in corneal
thickness with insignificant fluctuation through each tri-
mester of pregnancy has been reported [5].
Kiely et al [6] detected steepening of central curvatures in
both horizontal and vertical meridians at the beginning of
the cycle and flattening of them after ovulation in healthy
women. However until recent years, no report has been
published about the changes of corneal curvature in post-
menopausal women.
In the current study, we investigated the effect of meno-
pause on corneal curvature changes, the relation between
corneal topographic changes and sex-hormone levels in
premenopausal and postmenopausal healthy women.
Methods
Study design followed Institutional Research Ethics Board
guidelines, and informed consent was obtained. This ran-
domized, prospective study included twenty-six left eyes
of 26 premenopausal and thirty-six left eyes of 36 post-
menopausal healthy women were recruited for analysis of
corneal curvature changes depending on sex hormones.
Mean ages of premenopausal and postmenopausal sub-
jects were 38.5 (range 32 to 49 years) and 49.2 (range 39
to 57 years). We excluded the patients with contact lenses,
prior ocular surgery, dry eyes, inflammatory ocular dis-
ease, diabetes mellitus and hormone replacement ther-
apy.
All subjects underwent the following routine examination
by the same ophthalmologist and a certified ophthalmic
technician, however the evaluation of their corneal topog-
raphies were done by different ophthalmologist as a blind
study: (1) demographic and ocular history, (2) slit-lamp
biomicroscopy (Topcon) (3) manifest refraction (fogging
technique), (4) keratometry (Topcon) (5) videokeratogra-
phy (CTK 922 Haag-Streit Ag, Liebefeld, Switzerland). In
this system applanation tonometry was not performed
prior to keratography. No artificial method for widening
palpebral fissure (such as an eyelid speculum) was
applied. All measurements were obtained with Haag-
Streit corneal topographer. In this system the corneal cur-
vature is divided into 30 concentric circles. The curvature
is measured in dioptres (D), with each point representing
1 dioptre value, for a total of 7680 values (30*256). The
numeric data of the topographic maps were computerized
by a mathematical algorithm. One individual, specifically
trained in the use of the Haag-Streit instrument, per-
formed the topographical examinations. Testing was done
until acceptable quality imaging was obtained. The values
of quantitative topographic parameters were recorded as
central power (CP) of the cornea along the optical axis of
the instrument, expressed in dioptres. Hormone levels
(Follicular Stimulating Hormone (FSH), Luteinizing Hor-
mone (LH), Estradiol, and Progesterone) were deter-
mined after 8 hours of fasting. All hormone levels and
CVK were analyzed at luteal phase (after ovulation) in
premenopausal women. None of the subjects were pre-
scribed to use hormone replacement therapy.
For statistical evaluation, the two independent sample t-
tests were applied. Pearson correlation coefficient was per-
formed for relation among cornea vertical curvature, cor-
nea horizontal curvature and estrogen, progesterone
hormone levels. Since there was significant difference
between the ages of premenopausal and postmenopausal
groups, other variabilities adjusted with age were evalu-
ated by a multivariate analyze method (Hotelling T2 test).
All data were analyzed using Statistical Package program
(SPSS inc. Chicago, IL.)
Results
All subjects who met the criteria were consecutively
recruited for the study from June 2005 to April 2006.
Although there was no difference in the best-corrected vis-
ual acuity (BCVA) (P > 0.05), statistically significant dif-
ference was observed between the ages of premenopausal
and postmenopausal groups (P <0.05) (Table 1).
Mean horizontal curvature and vertical curvature of cen-
tral corneal power in premenopausal women were 43.5 ±
1.25 D, 44.1 ± 1.53D respectively. Mean horizontal curva-
ture and vertical curvature of central corneal power in
postmenopausal women were 43.9 ± 1.4D, 44.6 ± 1.3D;
the mean keratometric astigmatisms of premenopausal
and postmenopausal women were 0.81 ± 0.57D (4°–
179°), 0.74 ± 0.5D (1°–180°) respectively (Table 1).
We did not find significant corneal curvature changes
between premenopausal and postmenopausal women (P
> 0.05). On the other hand, when we investigated any cor-
relation between sex-hormones and corneal changes, we
detected negative but significant correlation between hor-
izontal corneal curvature and estrogen levels of postmen-BMC Ophthalmology 2007, 7:9 http://www.biomedcentral.com/1471-2415/7/9
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opausal women (r = -0.346, p = 0.038) (Figure 1). There
was no correlation among vertical, horizontal curvature
and progesterone level of premenopausal and postmeno-
pausal women.
The data on vertical, horizontal curvature of cornea and
and fasting blood sugar levels has been included in multi-
variate analyze and there was no significant difference in
vertical, horizontal curvature and fasting blood glucose
levels adjusted with age between premenopausal and
postmenopausal groups (P = 0.352, P = 0.250, P = 0.065,
respectively).
Discussion and conclusion
Estrogen receptors, ARs and PRs have been detected in the
human lacrimal [7,8] and meibomian glands [9] and have
been implicated in dry eye [10,11]. They were also found
in the nuclei of human corneal epithelial, stromal and
endothelial cells [1-3].
El Hage and Beaulne [12] reported that significant
changes in corneal topography occurred in relation with
time during menstrual cycle, with greatest alterations
occurring in the peripheral cornea. However, no signifi-
cant changes with time were detected for central and
peripheral corneal thickness measurement of eight
women. Kiely at al [6] investigated significant corneal
steeping at the beginning of the cycle in six women, in
addition cyclic changes in corneal thickness during the
menstrual cycle, and thickening of the cornea at ovula-
tion. Soni et al [13] found that female corneas attained
minimal thickness just before ovulation and maximal
thickness at the beginning or end of the menstrual cycle.
During pregnancy, Weinreb et al [14] detected an increase
in corneal thickness. Indeed, these reports seem to show a
strong association between corneal thickness and female
hormone levels, particularly estrogen level. In this circum-
stance, it is not apparent whether hormonal influence is
exerted through direct interaction in the cornea, or via sec-
ondary effects such as systemic water retention by estro-
gen-induced up regulation of the rennin-aldosterone
system [15]. Moreover, we have not found any published
research in literature related with the effect of menopause
on any changes of corneal curvature.
Corneal Topography provides a detailed depiction of the
corneal surface displaying its curvature, dioptres and
radial directions [16]. Steepening of central curvatures in
both horizontal and vertical meridians at the beginning of
the menstrual cycle, flattening of curvature after ovulation
in both meridians of healthy women was reported [6]. In
the present study, though no significant correlations were
found among estrogen, progesterone and corneal curva-
tures in premenopausal women, we investigated negative
The correlation between estradiol and cornea horizontal  curvature in postmenopausal women Figure 1
The correlation between estradiol and cornea horizontal 
curvature in postmenopausal women.
Table 1: Demographic and refractive data for premenopausal and postmenopausal women
Premenopausal (n = 26)
(Mean ± SD)
Postmenopausal (n = 36)
(Mean ± SD)
P-value
Age (year) 38.5 ± 4.9 49.2 ± 4.9 <0.001
BCVA (20/20 count) 26 36 1
Astigmatism 0.81 ± 0.57 D (4°–179°) 0.74 ± 0.5 D (1°–180°) 0.872
Horizontal curvature 43.5 ± 1.25 D 43.9 ± 1.4D 0.343
0.250*
Vertical curvature 44.1 ± 1.53D 44.6 ± 1.3D 0.170
0.352*
Estradiol level (pg/ml) 93.7 ± 33.4 22.37 ± 10.76 <0.001
Progesterone level (ng/ml) 6.36 ± 3.12 0.24 ± 0.11 <0.001
Fasting blood Sugar (mg/dl) 97.20 ± 7.46 100.86 ± 7.36 0.059
0.065*
*: Adjusted with age (Multivariate Analysis result)
SD: Standard deviation, BCVA: Best corrected visual acuity (Snellen), D: DiopterBMC Ophthalmology 2007, 7:9 http://www.biomedcentral.com/1471-2415/7/9
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but significant correlation between estrogen levels and
horizontal corneal curvatures in postmenopausal women.
In the sight of these findings, we speculate that decrease in
estrogen level of women in postmenopausal term may
cause steeping of corneal horizontal curvature.
Previous studies reported that astigmatism changes from
with the rule astigmatism, which is dominant in younger
ages, to against the rule astigmatism with aging [17,18].
Saunders implied that a gradual change of the astigmatic
axis reached an oblique mid-point in early middle life and
presented a new regression equation for the change of
astigmatism [19]. Hayashi et al evaluated the aging
changes in corneal shape and detected that the averaged
maps of subjects from < 20 years of age to the 40 s showed
a vertical bow-tie-rule astigmatism. In the maps of sub-
jects in their 50 s and 60 s, the central steep area gradually
extended horizontally until it became a round configura-
tion [20]. In our study, we did not find significant astig-
matic shift within premenopausal and postmenopausal
groups, but detected with-the-rule astigmatism in young
subject and oblique or against-the-rule astigmatism older
subjects. Mean astigmatism values also were similar in
both groups.
We considered that the present study was performed as
one masked, preliminary on limited number of subjects,
might result in biases; therefore more clinical trials are
needed with larger series of premenopausal, postmeno-
pausal groups and further follow-up time from premeno-
pausal to postmenopausal term.
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